IBM is trading 2.7% up at $259.89 as investors continue to react to its recently announced $2 billion quantum chip foundry partnership with the U.S. Department of Commerce.
- The stock has gained roughly $40 over the last four sessions, with traders pricing in long-term upside from a dedicated quantum chip production facility.
- Despite the rally, questions persist regarding commercialization timelines and whether the future-oriented bet fully justifies the rapid share price surge.